Inaugural World Sports Economy Summit Launches in London: A New Era of International Collaboration and Digital Innovation
LONDON, May 11, 2026 /PRNewswire/ — The inaugural World Sports Economy Summit (WSES) launched in London, marking a historic milestone as a premier international... Read more.
Broadridge Deploys Agentic AI at Institutional Scale Across Capital Markets and Wealth Operations
Powered by the Industry’s First Completed Financial Services Data Ontology, Broadridge’s AI Partnership Model Delivers Up to 30% Operational Cost Reduction... Read more.
Fuutura reveals first non-custodial multi-asset trading protocol with verified identity and self-custody at the protocol layer
Directed exclusively at persons outside the UK and other restricted jurisdictions. Not to be acted on by anyone inside a restricted jurisdiction. PANAMA CITY, May... Read more.
Players Gained Back Over $10M Through AskGamblers Casino Complaint Service in 2025
Driven by a year of record-breaking milestones, the AskGamblers Casino Complaint Service (AGCCS) successfully recovered more than $10 million for players in 2025,... Read more.
IFAT Munich 2026: Vary Tech, Evonik and SupeZET Launch Full-Chain Chemical Recycling Package for Waste Plastics to High-Quality PPO and Circular Naphtha
MUNICH, May 11, 2026 /PRNewswire/ — At IFAT Munich 2026, Vary Tech, a global leader in solid waste resource utilization, together with Evonik and SupeZET,... Read more.
Resideo Announces Filing of Form 10 Registration Statement for Planned Spin-Off of ADI Global Distribution
Names ADI and Resideo Leadership Teams and Boards of Directors Investor Days Scheduled for Mid-July to Provide Details on Resideo and ADI’s Go-Forward Business... Read more.
NextVision Updates 2026 Revenue Target to ~$315m, Representing 87% YoY growth
First Quarter Revenue Growth of 86% YoY to $67.4m and Net Income of $38.3m Doubling Production Capacity by the End of 2026 to Support Strong Demand North America... Read more.
Partner Therapeutics Announces FDA Approval of BIZENGRI® (Zenocutuzumab-zbco) for NRG1 Fusion-Positive Cholangiocarcinoma Following Receipt of FDA Commissioner’s National Priority Voucher
First Targeted Therapy Approved for NRG1+ Cholangiocarcinoma BIZENGRI Now Approved for Patients Harboring NRG1 Gene Fusions in Non-small Cell Lung Cancer, Pancreatic... Read more.
TrustCloud Introduces Agentic, Data-Driven Third Party Cyber Assessments to Replace Fundamentally Broken Questionnaire-Based Third Party Risk Management (TPRM)
Company Replaces Low-Confidence, Point-in-Time Workflows so Enterprises can Continuously Analyze Outside-in Security Feeds and Vendor Security Posture Artifacts... Read more.
Hello Group to Report First Quarter 2026 Results on June 2, 2026
BEIJING, May 11, 2026 /PRNewswire/ — Hello Group Inc. (NASDAQ: MOMO) (the “Company”), a leading player in Asia’s online social networking... Read more.